About us
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Since 2010, we invest in pioneering science that offers the potential to provide a significant benefit for our patients.
Since innovation is not restricted by geography, we invest worldwide.